| 1 |
Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2009. CA: A Cancer Journal for Clinicians, 2009, 59: 225-249.
|
| 2 |
Belt EJ, vSM, Bril H, et al. Lymph Node Negative Colorectal Cancers with Isolated Tumor Deposits Should Be Classified and Treated As Stage III. Ann Surg Oncol, 2010, 17 (12): 3203-3211.
|
| 3 |
Goldstein NS, T J. Pericolonic tumor deposits in patients with T3N+ MO colon adenocarcinomas: markers of reduced disease free survival and intra-abdominal metastases and their implications for TNM classification. Cancer, 2000, 88(10): 2228-2238.
|
| 4 |
Nakamura TMH, Kikuchi S, Ohtani Y, et al. Evaluation of the usefulness of tumor budding on the prediction of metastasis to the lung and liver after curative excision of colorectal cancer. Hepatogastroenterology 2005, 52(65): 1432-1435.
|
| 5 |
Kaneko ITS, Oka S, Kawamura T, et al. Lymphatic vessel density at the site of deepest penetration as a predictor of lymph node metastasis in submucosal colorectal cancer. Dis Colon Rectum, 2007, 50(1): 13-21.
|
| 6 |
吕其安, 康希保, 崔文, 等. 结直肠癌组织VEGF-C、Flt-4及Survivin表达与淋巴管生成及淋巴结转移关系的研究[J/CD]. 中华普通外科学文献:电子版, 2008, 2(4): 267-227.
|
| 7 |
Masaki T, G A, Sugiyama M,et al. Possible contribution of CD44 variant 6 and nuclear beta-catenin expression to the formation of budding tumor cells in patients with T1 colorectal carcinoma. Cancer, 2001, 92(10): 2539-2546.
|
|
Okuyama TOM, Ishikawa H. Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma. Dis Colon Rectum, 2002, 45(5): 628-634.
|
| 8 |
Okuyama TOM, Ishikawa H. Budding as a useful prognostic marker in pT3 well- or moderately-differentiated rectal adenocarcinoma. J Surg Oncol, 2003, 83(1): 42-47.
|